AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 150 filers reported holding AUDENTES THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $15,972,000 | +798.8% | 266,909 | +322.1% | 0.01% | +1100.0% |
| Q3 2019 | $1,777,000 | -21.6% | 63,238 | +5.6% | 0.00% | -50.0% |
| Q2 2019 | $2,267,000 | -1.2% | 59,888 | +1.9% | 0.00% | 0.0% |
| Q1 2019 | $2,294,000 | +113.2% | 58,777 | +16.5% | 0.00% | +100.0% |
| Q4 2018 | $1,076,000 | +24.4% | 50,467 | +130.9% | 0.00% | 0.0% |
| Q3 2018 | $865,000 | -5.4% | 21,853 | -8.7% | 0.00% | 0.0% |
| Q2 2018 | $914,000 | -11.8% | 23,941 | -30.7% | 0.00% | 0.0% |
| Q1 2018 | $1,036,000 | +125.7% | 34,533 | +134.7% | 0.00% | – |
| Q4 2017 | $459,000 | +34.6% | 14,713 | +20.7% | 0.00% | – |
| Q3 2017 | $341,000 | – | 12,190 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,204,615 | $36,198,681,000 | 11.58% |
| Sofinnova Investments, Inc. | 1,380,303 | $41,478,000 | 7.13% |
| Casdin Capital, LLC | 450,000 | $13,523,000 | 2.38% |
| Foresite Capital Management III, LLC | 315,331 | $9,476,000 | 2.06% |
| Opaleye Management Inc. | 190,000 | $5,709,000 | 1.63% |
| Redmile Group, LLC | 1,308,526 | $39,321,000 | 1.52% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,384,470 | $41,603,000 | 1.44% |
| Orbimed Advisors | 3,522,100 | $105,839,000 | 1.31% |
| Rock Springs Capital Management LP | 565,000 | $16,978,000 | 0.72% |
| Cormorant Asset Management, LP | 322,945 | $9,704,000 | 0.72% |